Mycodev Group takes mushrooms and makes them into medicine. The Mycodev team specializes in fungal fermentation – working to commercialize new technology and produce highly technical chitosan for the pharmaceutical industry. The vision is to derive ingredients sustainably from nature that can be used to solve problems in the healthcare industry.
Chitosan is used to treat obesity, high cholesterol, and Crohn’s disease. It is also used to treat complications that kidney failure patients on dialysis often face, including high cholesterol, “tired blood” (anemia), loss of strength and appetite, and trouble sleeping (insomnia).